Pfizer
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
PFE News
Pfizer Inc. has sold over £3 billion ($3.8 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce it...
Loading... Loading... Pfizer Inc PFE plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc HLN This move follows Pfizer’s earl...
Haleon PLC Sponsored ADR (HLN) has released an update. Haleon plc has announced Pfizer Inc.’s intention to sell approximately 630 million Haleon shares through...
Analyst ratings
60%
of 25 ratingsMore PFE News
Healthcare giant Pfizer (NYSE:PFE) plans to offload shares worth approximately $2.5 billion in consumer health company Haleon (NYSE:HLN). Pfizer is the largest...
(Bloomberg) -- Pfizer Inc. plans to sell about £2 billion ($2.5 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest sha...
Many investors have kicked value stocks to the curb in the new bull market. That's not surprising considering the jaw-dropping gains that several large-cap grow...
Pfizer Inc.’s oncology division is taking space at a newly built life-sciences complex in San Diego, as the pharma giant redefines itself as a cancer-drug power...
The stock market is at record levels these days, but one company that isn't reflecting that optimism is Pfizer (NYSE: PFE). Shares of the pharma giant are down...
Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's perf...
Two companies stand at the center of the obesity drug market right now. Novo Nordisk continues to rake in money from its weight-loss drug Wegovy (and from off-l...